Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1990 Mar;61(3):351–353. doi: 10.1038/bjc.1990.77

Where next with therapy in advanced neuroblastoma?

C R Pinkerton 1
PMCID: PMC1971292  PMID: 2183870

Full text

PDF
351

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. August C. S., Serota F. T., Koch P. A., Burkey E., Schlesinger H., Elkins W. L., Evans A. E., D'Angio G. J. Treatment of advanced neuroblastoma with supralethal chemotherapy, radiation, and allogeneic or autologous marrow reconstitution. J Clin Oncol. 1984 Jun;2(6):609–616. doi: 10.1200/JCO.1984.2.6.609. [DOI] [PubMed] [Google Scholar]
  2. Brodeur G. M., Seeger R. C., Barrett A., Berthold F., Castleberry R. P., D'Angio G., De Bernardi B., Evans A. E., Favrot M., Freeman A. I. International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol. 1988 Dec;6(12):1874–1881. doi: 10.1200/JCO.1988.6.12.1874. [DOI] [PubMed] [Google Scholar]
  3. Couanet D., Geoffray A. Etude en imagerie par résonance magnétique (IRM) des métastases ostéomédullaires des neuroblastomes. Bull Cancer. 1988;75(1):91–96. [PubMed] [Google Scholar]
  4. Draper G. J. Screening for neuroblastoma. BMJ. 1988 Jul 16;297(6642):152–153. doi: 10.1136/bmj.297.6642.152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gore M. E., Calvert A. H., Smith L. E. High dose carboplatin in the treatment of lung cancer and mesothelioma: a phase I dose escalation study. Eur J Cancer Clin Oncol. 1987 Sep;23(9):1391–1397. doi: 10.1016/0277-5379(87)90125-8. [DOI] [PubMed] [Google Scholar]
  6. Hartmann O., Benhamou E., Beaujean F., Kalifa C., Lejars O., Patte C., Behard C., Flamant F., Thyss A., Deville A. Repeated high-dose chemotherapy followed by purged autologous bone marrow transplantation as consolidation therapy in metastatic neuroblastoma. J Clin Oncol. 1987 Aug;5(8):1205–1211. doi: 10.1200/JCO.1987.5.8.1205. [DOI] [PubMed] [Google Scholar]
  7. Hartmann O., Kalifa C., Benhamou E., Patte C., Flamant F., Jullien C., Beaujean F., Lemerle J. Treatment of advanced neuroblastoma with high-dose melphalan and autologous bone marrow transplantation. Cancer Chemother Pharmacol. 1986;16(2):165–169. doi: 10.1007/BF00256169. [DOI] [PubMed] [Google Scholar]
  8. Hayes F. A., Green A. A., Casper J., Cornet J., Evans W. E. Clinical evaluation of sequentially scheduled cisplatin and VM26 in neuroblastoma: response and toxicity. Cancer. 1981 Oct 15;48(8):1715–1718. doi: 10.1002/1097-0142(19811015)48:8<1715::aid-cncr2820480805>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  9. Hill B. T. Neuroblastoma--an overview of laboratory studies aimed at inducing tumor regression by initiation of differentiation or administration of antitumor drugs. Pediatr Hematol Oncol. 1986;3(1):73–88. doi: 10.3109/08880018609031203. [DOI] [PubMed] [Google Scholar]
  10. Ho A. D., Thaler J., Willemze R., Lauria F., Derossi G., Kuse R., Stryckmans P., Blanc C. M., Cataldo F., McVie G. Pentostatin (2'deoxycoformycin) for the treatment of lymphoid neoplasms. Bone Marrow Transplant. 1989 Jan;4 (Suppl 1):60–62. [PubMed] [Google Scholar]
  11. Kellie S. J., De Kraker J., Lilleyman J. S., Bowman A., Pritchard J. Ifosfamide in previously untreated disseminated neuroblastoma. Results of Study 3A of the European Neuroblastoma Study Group. Eur J Cancer Clin Oncol. 1988 May;24(5):903–908. doi: 10.1016/0277-5379(88)90200-3. [DOI] [PubMed] [Google Scholar]
  12. Kushner B. H., Helson L. Coordinated use of sequentially escalated cyclophosphamide and cell-cycle-specific chemotherapy (N4SE protocol) for advanced neuroblastoma: experience with 100 patients. J Clin Oncol. 1987 Nov;5(11):1746–1751. doi: 10.1200/JCO.1987.5.11.1746. [DOI] [PubMed] [Google Scholar]
  13. McElwain T. J., Hedley D. W., Gordon M. Y., Jarman M., Millar J. L., Pritchard J. High dose melphalan and non-cryopreserved autologous bone marrow treatment of malignant melanoma and neuroblastoma. Exp Hematol. 1979;7 (Suppl 5):360–371. [PubMed] [Google Scholar]
  14. Ninane J., Pritchard J., Malpas J. S. Chemotherapy of advanced neuroblastoma: does adriamycin contribute? Arch Dis Child. 1981 Jul;56(7):544–548. doi: 10.1136/adc.56.7.544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Philip T., Bernard J. L., Zucker J. M., Pinkerton R., Lutz P., Bordigoni P., Plouvier E., Robert A., Carton R., Philippe N. High-dose chemoradiotherapy with bone marrow transplantation as consolidation treatment in neuroblastoma: an unselected group of stage IV patients over 1 year of age. J Clin Oncol. 1987 Feb;5(2):266–271. doi: 10.1200/JCO.1987.5.2.266. [DOI] [PubMed] [Google Scholar]
  16. Philip T., Ghalie R., Pinkerton R., Zucker J. M., Bernard J. L., Leverger G., Hartmann O. A phase II study of high-dose cisplatin and VP-16 in neuroblastoma: a report from the Société Française d'Oncologie Pédiatrique. J Clin Oncol. 1987 Jun;5(6):941–950. doi: 10.1200/JCO.1987.5.6.941. [DOI] [PubMed] [Google Scholar]
  17. Pinkerton C. R., Lewis I. J., Pearson A. D., Stevens M. C., Barnes J. Carboplatin or cisplatin? Lancet. 1989 Jul 15;2(8655):161–161. doi: 10.1016/s0140-6736(89)90217-1. [DOI] [PubMed] [Google Scholar]
  18. Pritchard J., Kiely E., Rogers D. W., Spitz L., Shafford E. A., Brereton R., Muller C., Wright V. M. Long-term survival after advanced neuroblastoma. N Engl J Med. 1987 Oct 15;317(16):1026–1027. doi: 10.1056/NEJM198710153171611. [DOI] [PubMed] [Google Scholar]
  19. Shafford E. A., Rogers D. W., Pritchard J. Advanced neuroblastoma: improved response rate using a multiagent regimen (OPEC) including sequential cisplatin and VM-26. J Clin Oncol. 1984 Jul;2(7):742–747. doi: 10.1200/JCO.1984.2.7.742. [DOI] [PubMed] [Google Scholar]
  20. Thiele C. J., Reynolds C. P., Israel M. A. Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma. 1985 Jan 31-Feb 6Nature. 313(6001):404–406. doi: 10.1038/313404a0. [DOI] [PubMed] [Google Scholar]
  21. de Kraker J., Pritchard J., Hartmann O., Ninane J. Single-agent ifosfamide in patients with recurrent neuroblastoma (ENSG study 2). European Neuroblastoma Study Group. Pediatr Hematol Oncol. 1987;4(2):101–104. doi: 10.3109/08880018709141255. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES